Skip to content

Dr. Robeyns Kathleen

Active Private limited companyfounded 2016active for 10 yearsVogelzang 14, 2460 KasterleeKBO/BCE: BE 0649.535.952

Lifetime

10 annual accounts with figures on one time axis
peak of €114,326 in 2025
€114,326▲ 16.8%
peak of €76,752 in 2021
€66,973▲ 25.9%
peak of €182,402 in 2019
€18,600unchanged
€162,545▲ 0.3%
Board2 names since 2016
2 directors and 1 other
Documentsfilings and deeds
18-03-2026135 days before the deadline
2025micro format
Gross margin from €97,908 to €114,326Result from €53,182 to €66,973Dividend €66,973

Key points

from the 2025 annual accounts

Equity

€18,600 from €182,402 in 2019

Equity fell by 90% in 6 years.

Debts

€162,545 90% of the balance sheet
Financial debts 18%Suppliers 1%Taxes and wages 1%Other 80%

Of this, €124,626 falls due within a year.

Filings

10 annual accounts 5 late
AprilJune31 JulyOctober20202025

The 2020 accounts came in latest, 60 days after the end of the period.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 5,052 companies had the same profile as Dr. Robeyns Kathleen has now. Each dot stands for 13 companies, two years later.

95.9%
were still trading
2.4%
stopped another way
1.6%
went bankrupt
  • Micro
  • 10 to 20 years old
  • solvency 10 to 30%
  • a profit of 5% of the balance sheet or more

Another 0.1% stopped without a precise date, possibly only after those two years.

Test of the method

The method was tested on the 497,965 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 5,052 companies, not a prediction for Dr. Robeyns Kathleen. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director, since 09-02-2016
Manager, since 09-02-2016
  • founderdeed of 03-03-2016
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0649535952
appointed as director Gazette deed
Incorporation Founding capital of €18,600, 186 shares · Founded by · appointed as manager · published on 03-03-2016 · Gazette deed
First establishment Vogelzang 14, Kasterlee
All 18 events

Comparable companies

same main activity, similar in size and age
Company
Dr. Robeyns Kathleen Kasterlee €181,145 €114,326 10.3% -
Dr. Yves Vloemans Kasterlee €185,949 €109,805 46.8% -
Dr. Karolien Vaes Heist-op-den-Berg €205,006 €110,813 19.8% -
Dr. Tom Lambrechts Huisarts Arendonk €159,508 €112,371 53.7% -
Dokter Els Schuurmans Hamont-Achel €165,597 €121,597 29.6% -
Dokter Kelly Veuskens Oudsbergen €191,136 €102,074 44.4% -
DR NATHALIE THEUNISSEN Kasterlee €200,181 €126,873 54.6% -

These companies have the same main activity as Dr. Robeyns Kathleen: general medical practice (NACE 86210). They are comparable in size and age: total assets between €160,000 and €205,000, founded between 2015 and 2019.

Official details

Source: KBO
Status
Active since 01-03-2016Normal situation
Activity
General medical practiceNACE 86210
Establishment unit
2.250.666.0562460 Kasterlee, since 01-03-2016
Financial year end
31 December
Peppol
Reachable since 15-12-2025
Company details

Annual accounts 2025

≈ €210,000estimated
€181,145▲ 0.3%
≈ 0.1 FTEestimated
Filing
Filed on 18-03-2026, 135 days before the end of the filing period
Financials

Insights on Dr. Robeyns Kathleen

Dr. Robeyns Kathleen files the micro format. That format states no turnover. The gross margin rose from €77,912 in 2016 to €114,326 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about Dr. Robeyns Kathleen

What is the company number of Dr. Robeyns Kathleen?
The company number of Dr. Robeyns Kathleen is 0649.535.952. The VAT number is the same number with BE in front: BE 0649.535.952.
Where is Dr. Robeyns Kathleen based?
The registered office is at Vogelzang 14, 2460 Kasterlee.Company details
What does Dr. Robeyns Kathleen do?
According to the KBO register, the main activity is general medical practice (NACE 86210).
What is the legal form of Dr. Robeyns Kathleen?
Dr. Robeyns Kathleen is a private limited company (BV).
When was Dr. Robeyns Kathleen founded?
Dr. Robeyns Kathleen was founded on 01-03-2016.
Is Dr. Robeyns Kathleen still active?
Yes, Dr. Robeyns Kathleen is an active enterprise in the KBO register.
What is the turnover of Dr. Robeyns Kathleen?
The turnover in financial year 2025 is ≈ €210,000. This figure is estimated from the gross margin of €114,326 and 30 comparable companies (NACE 86210). It probably lies between €170,000 and €260,000.Financials
Is Dr. Robeyns Kathleen profitable?
In financial year 2025, Dr. Robeyns Kathleen made a profit of €66,973.
Where can I find the annual accounts of Dr. Robeyns Kathleen?
Dr. Robeyns Kathleen filed 10 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Dr. Robeyns Kathleen due?
Dr. Robeyns Kathleen must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.